Regulation of Signaling in Osteoclast Bone Resorption

破骨细胞骨吸收中信号传导的调节

基本信息

  • 批准号:
    6869350
  • 负责人:
  • 金额:
    $ 30.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-08-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this proposal is to elucidate the molecular mechanisms involved in actin ring formation and bone resorption. Bone resorption is the first step in bone remodeling. Actin ring formation has been shown to be a prerequisite for efficient bone resorption in osteoclasts. Recent preliminary studies from our laboratory suggest that N-WASP-Arp2/3 complex may have a role in the osteoclast actin ring formation. Tyrosine kinases such as PYK2 and Src are involved in the phosphorylation of N-WASP and N-WASP associated phosphoproteins. Moreover, tyrosine phosphatase (PTP-PEST) has a unique role in the modulation of tyrosine phosphorylation of N-WASP and the associated signaling molecules. We therefore hypothesize: 1. N-WASP coordinately activated by Cdc42, PtdIns P2 (PIP2), and kinase(s) can stimulate Arp2/3 mediated actin polymerization and actin ring formation in osteoclasts. 2. Src/PTP-PEST regulation of tyrosine phosphorylation of N-WASP and the associated signaling proteins is required for actin remodeling in the actin ring and bone resorption. Thus, our Specific Aims are to: 1. Determine the signal transduction mechanisms involved in N-WASP activation and actin ring formation. 2. Determine the regulation of tyrosine phosphorylation, actin ring formation, and bone resorption by PTP-PEST. The goal of this revised renewal application is to identify the underlying molecular mechanisms in actin ring formation. To advance the understanding of the mechanisms of bone resorption at the cellular and molecular level, different approaches will be used. HIV-TAT or adenoviral-mediated delivery of N-WASP, PTP-PEST, and kinases (Src and PYK2) into osteoclasts will be performed to identify the signal transduction mechanisms involved in the formation of N-WASP-Arp2/3 complex and actin ring. The binding sites of PTP-PEST with N-WASP will be characterized by the delivery of TAT-fused oligopeptides derived from proline-rich regions of PTP-PEST and N-WASP. We will analyze the effects of the above-mentioned treatments on actin ring formation and bone resorption. Identification of peptides that impede osteoclast function will be useful in the development of pharmacological agents, targeting osteoclast actin ring formation and bone resorption in disorders such as osteoporosis, periodontal disease, and osteoarthritis.
描述(由申请人提供):该提案的长期目标是阐明与肌动蛋白环形成和骨吸收有关的分子机制。骨吸收是骨骼重塑的第一步。肌动蛋白环的形成已被证明是在破骨细胞中有效骨吸收的先决条件。我们实验室的最新初步研究表明,N-WASP-ARP2/3复合物可能在破骨细胞肌动蛋白环形成中起作用。酪氨酸激酶(如Pyk2和SRC)参与N-WASP和N-WASP相关的磷酸蛋白的磷酸化。此外,酪氨酸磷酸酶(PTP-PEST)在N-WASP酪氨酸磷酸化和相关信号分子的调节中具有独特的作用。因此,我们假设:1。N-WASP通过CDC42,PTDINS P2(PIP2)和激酶(S)协调激活,可以刺激破骨细胞中ARP2/3介导的肌动蛋白聚合和肌动蛋白环的形成。 2。N-WASP的酪氨酸磷酸化和相关信号蛋白的SRC/PTP-PEST调节对于肌动蛋白重塑肌动蛋白环和骨吸收是必需的。因此,我们的具体目的是:1。确定与N-WASP激活和肌动蛋白环形成有关的信号转导机制。 2。确定酪氨酸磷酸化,肌动蛋白环形成和骨骼吸收的调节。此修订后的更新应用的目的是确定肌动蛋白环形成中的基本分子机制。为了促进对细胞和分子水平上骨吸收机制的理解,将使用不同的方法。 HIV-TAT或腺病毒介导的N-WASP,PTP-PEST和激酶(SRC和PYK2)将进行破骨细胞,以确定与N-WASP-ARP2/3复合物形成的信号转导机制。 PTP-PEST与N-WASP的结合位点的特征是衍生自PTP-PEST和N-WASP富含脯氨酸区域的TAT融合寡肽。我们将分析上述处理对肌动蛋白环形成和骨吸收的影响。阻碍破骨细胞功能的肽的鉴定将在药理学剂的发育中有用,靶向骨质骨肌动蛋白环的形成和骨骼疏松症,牙周疾病和骨关节炎等疾病的骨吸收。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MEENAKSHI A CHELLAIAH其他文献

MEENAKSHI A CHELLAIAH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MEENAKSHI A CHELLAIAH', 18)}}的其他基金

L-plastin: a novel target for intervention in the treatment of osteoporosis
L-plastin:干预治疗骨质疏松症的新靶点
  • 批准号:
    8816501
  • 财政年份:
    2014
  • 资助金额:
    $ 30.41万
  • 项目类别:
L-plastin: a novel target for intervention in the treatment of osteoporosis
L-plastin:干预治疗骨质疏松症的新靶点
  • 批准号:
    8927529
  • 财政年份:
    2014
  • 资助金额:
    $ 30.41万
  • 项目类别:
Regulation of Signaling in Osteoclast Bone Resorption
破骨细胞骨吸收中信号传导的调节
  • 批准号:
    6954116
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
GELSOLIN BASED SIGNALING IN OSTEOCLAST FUNCTION
破骨细胞功能中基于凝溶胶蛋白的信号传导
  • 批准号:
    2899946
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
GELSOLIN BASED SIGNALING IN OSTEOCLAST FUNCTION
破骨细胞功能中基于凝溶胶蛋白的信号传导
  • 批准号:
    6532990
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
GELSOLIN BASED SIGNALING IN OSTEOCLAST FUNCTION
破骨细胞功能中基于凝溶胶蛋白的信号传导
  • 批准号:
    6171383
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
GELSOLIN BASED SIGNALING IN OSTEOCLAST FUNCTION
破骨细胞功能中基于凝溶胶蛋白的信号传导
  • 批准号:
    6375251
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
Regulation of Signaling in Osteoclast Bone Resorption
破骨细胞骨吸收中信号传导的调节
  • 批准号:
    7088781
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:
Regulation of Signaling in Osteoclast Bone Resorption
破骨细胞骨吸收中信号传导的调节
  • 批准号:
    7257298
  • 财政年份:
    1999
  • 资助金额:
    $ 30.41万
  • 项目类别:

相似海外基金

Mechanosensor Proteins in Hair Cell Repair
毛细胞修复中的机械传感器蛋白
  • 批准号:
    10718860
  • 财政年份:
    2023
  • 资助金额:
    $ 30.41万
  • 项目类别:
SSH1-Nrf2 nexus in tipping the balance between degeneration and protection in tauopathies.
SSH1-Nrf2 关系打破了 tau蛋白病中退化和保护之间的平衡。
  • 批准号:
    10605657
  • 财政年份:
    2022
  • 资助金额:
    $ 30.41万
  • 项目类别:
Prune Belly Syndrome: Mechanisms of Filamin A Mutations
李子腹综合症:Filamin A 突变机制
  • 批准号:
    10675735
  • 财政年份:
    2022
  • 资助金额:
    $ 30.41万
  • 项目类别:
LIM domain kinases: regulation and substrate recognition
LIM 结构域激酶:调节和底物识别
  • 批准号:
    10443356
  • 财政年份:
    2022
  • 资助金额:
    $ 30.41万
  • 项目类别:
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1
ALS 相关突变对 profilin-1 结构、动力学和功能的影响
  • 批准号:
    10323045
  • 财政年份:
    2021
  • 资助金额:
    $ 30.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了